Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005761 · ClinicalTrials.gov registry record

Blood Factors and Diabetic Retinopathy

A clinical trial, sponsored by National Eye Institute (NEI).

Completed
Registry status
173
Enrollment target

NCT00005761 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 173 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005761 has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
173 participants
Enrollment target

Study Summary

This study will determine whether certain factors in the blood are associated with the severity of diabetic retinopathy. Patients age 10 years and older with diabetes mellitus and diabetic retinopathy may be eligible for this study. Those enrolled will represent a range of diabetic retinopathy from minimal to severe. Participants will undergo the following procedures: * medical history * thorough eye examination * photographs of the eye * blood tests to measure blood lipids (cholesterol and triglycerides) and serum creatinine (for kidney function) * blood tests to measure levels of blood factors (cell adhesion molecules, chemokines and vascular endothelial growth factor) that may be related to the progression of diabetic retinopathy * blood pressure measurement * urinalysis This study may lead to a better understanding of how diabetic retinopathy develops and progresses.

Trial Details

FieldValue
Enrollment Target 173 participants
Start Date 2000-05-23
Est. Completion 2010-12-07

Sponsor

National Eye Institute (NEI)

221 total trials

What the Registry Record Tells You About NCT00005761

The ClinicalTrials.gov registry entry for NCT00005761 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00005761 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00005761 about?

NCT00005761 is a clinical study titled "Blood Factors and Diabetic Retinopathy". This study will determine whether certain factors in the blood are associated with the severity of diabetic retinopathy. Patients age 10 years and older with diabetes mellitus and diabetic retinopathy may be eligible for this study. Those enrolled will represent a range of diabetic retinopathy from...

What is the current status of trial NCT00005761?

This trial is currently completed. The enrollment target is 173 participants. The study started on 2000-05-23. Estimated completion is 2010-12-07.

Who is sponsoring clinical trial NCT00005761?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.